Tougeron, D., Emile, J. F., Kim, S., Monterymard, C., Gilabert, M., Jérémie, B., Lievre, A., Dahan, L., Laurent-puig, P., Mineur, L., Coriat, R., Legoux, J. L., Hautefeuille, V., Phelip, J. m., Lecomte, T., Sokol, H., Capron, C., Gallois, C., Randrian, V., Lepage, C., & Taieb, J. (n.d.). 337 Pembrolizumab in combination with xelox bevacizumab in patients with microsatellite stable (MSS) metastatic colorectal cancer and a high immune infiltrate: a proof of concept study. FFCD 1703 POCHI. Journal for immunotherapy of cancer, 8, A206. http://access.bl.uk/ark:/81055/vdc_100144719406.0x000005